Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension

NCT05135000 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

47

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: LTP001
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals